Literature DB >> 19048364

Insertion and deletion in a non-essential region of the nonstructural protein 2 (nsp2) of porcine reproductive and respiratory syndrome (PRRS) virus: effects on virulence and immunogenicity.

Dal-Young Kim1, Troy J Kaiser, Kyle Horlen, Marcia L Keith, Lucas P Taylor, Rika Jolie, Jay G Calvert, Raymond R R Rowland.   

Abstract

Developing a vaccine that can differentiate infected and vaccinated animals (DIVA) is a new challenge in the design of a vaccine for porcine reproductive and respiratory syndrome virus (PRRSV). Nonstructural protein 2 (nsp2) is the single largest viral product, and it has multiple roles in polypeptide processing and replication complex formation. Using reverse genetics and an infectious PRRSV cDNA clone, we constructed several deletion mutants in the non-essential region of nsp2. One mutant, which has a 131 amino acid deletion within a relatively conserved region of nsp2, was recovered and found to produce a viable virus. The deleted region was replaced with a peptide tag encoding eight amino acids. A recombinant virus containing the 131 amino acid deletion was found to produce normal virus yields in MARC-145 cells and porcine alveolar macrophages (PAM); however, gross and micro-histopathology showed that the virus was less virulent in pigs. The 131 amino acid peptide was expressed as a recombinant protein and used to coat enzyme-linked immunosorbent assay (ELISA) plates. This peptide was recognized by sera from pigs infected with wild-type virus, but not by sera from pigs infected with the deletion mutant. The results from this study show that nsp2 is an important target for the development of marker vaccines and for virus attenuation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19048364     DOI: 10.1007/s11262-008-0303-4

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  25 in total

1.  Examination of the selective pressures on a live PRRS vaccine virus.

Authors:  T Storgaard; M Oleksiewicz; A Bøtner
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

2.  An efficient system for high-level expression and easy purification of authentic recombinant proteins.

Authors:  Ann-Maree Catanzariti; Tatiana A Soboleva; David A Jans; Philip G Board; Rohan T Baker
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

Review 3.  The molecular biology of arteriviruses.

Authors:  E J Snijder; J J Meulenberg
Journal:  J Gen Virol       Date:  1998-05       Impact factor: 3.891

4.  A DNA-launched reverse genetics system for porcine reproductive and respiratory syndrome virus reveals that homodimerization of the nucleocapsid protein is essential for virus infectivity.

Authors:  Changhee Lee; Jay G Calvert; Siao-Kun W Welch; Dongwan Yoo
Journal:  Virology       Date:  2005-01-05       Impact factor: 3.616

5.  Generation of an infectious clone of VR-2332, a highly virulent North American-type isolate of porcine reproductive and respiratory syndrome virus.

Authors:  H S Nielsen; G Liu; J Nielsen; M B Oleksiewicz; A Bøtner; T Storgaard; K S Faaberg
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  Serologic marker candidates identified among B-cell linear epitopes of Nsp2 and structural proteins of a North American strain of porcine reproductive and respiratory syndrome virus.

Authors:  Marcelo de Lima; Asit K Pattnaik; Eduardo F Flores; Fernando A Osorio
Journal:  Virology       Date:  2006-07-14       Impact factor: 3.616

7.  Viable porcine arteriviruses with deletions proximal to the 3' end of the genome.

Authors:  M H Verheije; M V Kroese; P J M Rottier; J J M Meulenberg
Journal:  J Gen Virol       Date:  2001-11       Impact factor: 3.891

8.  Genetic polymorphism of the nsp2 gene in North American type--porcine reproductive and respiratory syndrome virus.

Authors:  Masaaki Yoshii; Tatsuyuki Okinaga; Ayako Miyazaki; Kanako Kato; Hidetoshi Ikeda; Hiroshi Tsunemitsu
Journal:  Arch Virol       Date:  2008-06-10       Impact factor: 2.574

9.  Expression and stability of foreign tags inserted into nsp2 of porcine reproductive and respiratory syndrome virus (PRRSV).

Authors:  Dal-Young Kim; Jay G Calvert; Kyeong-Ok Chang; Kyle Horlen; Maureen Kerrigan; Raymond R R Rowland
Journal:  Virus Res       Date:  2007-06-05       Impact factor: 3.303

10.  Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses.

Authors:  Natalia Frias-Staheli; Nadia V Giannakopoulos; Marjolein Kikkert; Shannon L Taylor; Anne Bridgen; Jason Paragas; Juergen A Richt; Raymond R Rowland; Connie S Schmaljohn; Deborah J Lenschow; Eric J Snijder; Adolfo García-Sastre; Herbert Whiting Virgin
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

View more
  21 in total

1.  A new porcine reproductive and respiratory syndrome virus strain with highly conserved molecular characteristics in its parental and attenuated strains.

Authors:  Xing Liu; Yufeng Li; Qi Lu; Juan Bai; Xiaoye Wang; Ping Jiang
Journal:  Virus Genes       Date:  2014-05-25       Impact factor: 2.332

2.  The nsp2 Hypervariable Region of Porcine Reproductive and Respiratory Syndrome Virus Strain JXwn06 Is Associated with Viral Cellular Tropism to Primary Porcine Alveolar Macrophages.

Authors:  Jiangwei Song; Peng Gao; Can Kong; Lei Zhou; Xinna Ge; Xin Guo; Jun Han; Hanchun Yang
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

3.  Distribution of genotypes of porcine reproductive and respiratory syndrome virus in Ontario during 2004-2007 and the association between genotype and clinical signs of disease.

Authors:  Thomas Rosendal; Cate Dewey; Beth Young; Susy Carman; Li Ge; Zvonimir Poljak
Journal:  Can J Vet Res       Date:  2010-04       Impact factor: 1.310

4.  An Attenuated Highly Pathogenic Chinese PRRS Viral Vaccine Confers Cross Protection to Pigs against Challenge with the Emerging PRRSV NADC30-Like Strain.

Authors:  Hewei Zhang; Mingqi Xia; Wei Wang; Decai Ju; Long Cao; Bai Wu; Xin Wang; Ying Wu; Ni Song; Jiaxin Hu; Changxiao Tian; Shucheng Zhang; Hua Wu
Journal:  Virol Sin       Date:  2018-03-29       Impact factor: 4.327

5.  Development of monoclonal antibody for differentiating porcine reproductive and respiratory syndrome virus and identification of a novel non-structural protein 2 epitope peptide.

Authors:  Feng-Xue Wang; Yong Yang; Xing Liu; Min-Hui He; Ying Liu; Na Sun; Hong-Wei Zhu; Jing-Qiang Ren; Hua Wu; Yong-Jun Wen
Journal:  Virusdisease       Date:  2017-11-10

6.  Use of reverse genetics to develop a novel marker porcine reproductive and respiratory syndrome virus.

Authors:  Tao Lin; Xiangrui Li; Huochun Yao; Zuzhang Wei; Feifei Tan; Runxia Liu; Lichang Sun; Rong Zhang; Wenliang Li; Jiaqi Lu; Guangzhi Tong; Shishan Yuan
Journal:  Virus Genes       Date:  2012-08-31       Impact factor: 2.332

7.  Association between the genetic similarity of the open reading frame 5 sequence of Porcine reproductive and respiratory syndrome virus and the similarity in clinical signs of Porcine reproductive and respiratory syndrome in Ontario swine herds.

Authors:  Thomas Rosendal; Cate Dewey; Robert Friendship; Sarah Wootton; Beth Young; Zvonimir Poljak
Journal:  Can J Vet Res       Date:  2014-10       Impact factor: 1.310

8.  Antiviral regulation in porcine monocytic cells at different activation states.

Authors:  Yongming Sang; Raymond R R Rowland; Frank Blecha
Journal:  J Virol       Date:  2014-07-23       Impact factor: 5.103

9.  Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus.

Authors:  Hiep L X Vu; Byungjoon Kwon; Marcelo de Lima; Asit K Pattnaik; Fernando A Osorio
Journal:  Vaccine       Date:  2013-07-23       Impact factor: 3.641

10.  Whole-Genome Sequencing of Porcine Reproductive and Respiratory Syndrome Virus from Field Clinical Samples Improves the Genomic Surveillance of the Virus.

Authors:  Christian Lalonde; Chantale Provost; Carl A Gagnon
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.